Drugs: the complete collection

SnortingEffectiveness bank home page. Opens new window Collection
Drugs: the complete collection

All Effectiveness Bank analyses to date of documents related to use and problem use of illegal drugs starting with the analyses most recently added or updated, totalling today 743 documents.

Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents

Drug Treatment Matrix cell E4: Treatment systems; Psychosocial therapies

Ashton M.
Seminal and key studies on local, regional and national systems for effectively and cost-effectively providing psychosocial therapies and the place of those therapies within these systems. Asks whether mutual aid groups can bridge the widening gap between resources and recovery ambitions, whether residential rehabilitation should be a last resort, and how tightly commissioners should specify services.

STUDY 2018 HTM file
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom

Hickman M., Steer C., Tilling K. et al.
Addiction: 2018, 113(8), p. 1461–1476.
Please come back again soon. This entry is under construction.

STUDY 2016 HTM file
Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: A cluster randomized controlled trial

Champion K.E., Newton N.C., Stapinski L.A. et al.
Addiction: 2016, 111, p. 1396–1405.
An online course implemented in Australian secondary schools improved on standard health and drug education by reducing intentions to use new psychoactive substances and in the short-term increasing knowledge about these substances and about ecstasy.

STUDY 2012 HTM file
Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial

Manning V., Best D., Faulkner N. et al.
Drug and Alcohol Dependence: 2012, 126(1–2), p. 131–137.
In the context of current UK policy, this is a key study, testing the ambition to extend recovery beyond formal treatment by systematically linking patients to mutual aid groups, the main way it is being suggested commissioners can square the circle of doing more (recovery is seen as a whole-life transformation) with less.

Drug Treatment Matrix cell D4: Organisational functioning; Psychosocial therapies

Ashton M.
Key studies on how treatment organisations affect the implementation and effectiveness of psychosocial therapies for drug dependence. See if you agree that “organizational climate underlies the entire process of innovation adoption”, appreciate the obstructive effect of high staff turnover and how to reduce it, ask yourself, “Is my service even ready for change?” – and explore whether change driven by money is just as good for patients as that motivated by a desire to improve their lives.

Drug Treatment Matrix cell C4: Management/supervision; Psychosocial therapies

Ashton M.
Seminal and key studies on management and supervision in psychosocial therapies. Findings challenge managers to invest in the post-training ‘coaching’ needed to make a difference for patients, and to set up systems alerting therapists to how well their clients are doing – especially when they are doing badly.

STUDY 2014 HTM file
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial

Fiellin D.A., Schottenfeld R.S., Cutter C.J. et al.
JAMA Internal Medicine: 2014, 174(12), p. 1947–1954.
Among patients dependent on prescription opioids, ongoing maintenance therapy using a legal opiate substitute (buprenorphine–naloxone) produced better outcomes than tapered withdrawal, with patients less likely to have used illicit opioids and considerably more likely to have remained in their allocated treatment.

Drug Treatment Matrix cell B4: Practitioners; Psychosocial therapies

Ashton M.
Seminal and key studies on the impact of the practitioner in psychosocial therapies. Takes Carl Rogers’s seminal theories as its starting point and guides you through the complexities which obscure the impact of client-worker relationships despite their patent important to the clients.

Drug Treatment Matrix cell A4: Interventions; Psychosocial therapies

Ashton M.
Seminal and key studies shedding light on the general principles underpinning psychosocial therapies and the effectiveness specific approaches. ’Individualise,’ is the overarching theme … and the consequent dangers of inflexibly following guidelines and research findings.

STUDY 2016 HTM file
Extended-release naltrexone to prevent opioid relapse in criminal justice offenders

Lee J.D., Friedmann P.D., Kinlock T.W. et al.
New England Journal of Medicine: 2016, 374, p. 1232–1242.
Added to basic counselling alone, monthly injections of the opioid-blocking drug naltrexone helped prevent relapse among US offenders with a history of opioid dependence recently released from prison or under criminal justice supervision in the community – findings most applicable to those who prefer opioid-free to opioid-maintenance treatments.

Select search results page

NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75